You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
陽普醫療(300030.SZ):新型冠狀病毒檢測試劑盒已完成設計及內部驗證
格隆匯 03-09 18:57

格隆匯3月9日丨陽普醫療(300030.SZ)公佈,公司股票於2020年3月6日、2020年3月9日連續兩個交易日收盤價格漲幅偏離值累計超過20%。

目前,公司除個別人員因疫情防控居家隔離外,其餘人員均已正常復工,公司經營情況正常,內外部經營環境未發生重大變化。疫情防控期間,公司在做好自身防疫工作的同時,適當調整產業結構,在關鍵時期向健康防護、病毒檢驗等產品傾斜,從產品的質量和產能兩個方面最大限度滿足市場需求。

陽普醫療研發的新型冠狀病毒檢測試劑盒適用於杭州子公司康代思鋭生物科技公司自主研發的Q-velox平台,該檢測系統獨立、封閉、全自動、體積小,能夠快速為基層醫療機構提供標準化的檢測和診斷能力。受疫情影響,杭州地區相關企業復工延遲,導致進展延後。目前,新型冠狀病毒的檢測試劑盒已經完成設計及內部驗證,正在進行註冊證申報的準備工作,相關進展請留意後續公告。

受新型冠狀病毒肺炎疫情影響,公司全自動脱蓋機、核酸檢測採血管、樣本保存液、拭子、口罩等疫情相關產品需求激增,但由於原材料、人工及物流成本升高及終端價格控制等原因,該類產品銷售對公司業績的影響存在不確定性,此外,該產品的實際銷售情況取決於產品供求變化情況及未來市場推廣效果,請廣大投資者注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account